Peter Diamandis on the future of longevity: A bold vision for anti-aging technology
Lifespan.io (LEAF) - 20-Aug-2024Peter Diamandis shares insights on living longer through tech innovation
Join the club for FREE to access the whole archive and other member benefits.
Founder/co-founder of XPRIZE, Singularity University, Human Longevity Inc., and more
Recently named by Fortune as one of the “World’s 50 Greatest Leaders,” Peter H. Diamandis is the founder and executive chairman of the XPRIZE Foundation, which leads the world in designing and operating large-scale incentive competitions. He is also the executive founder of Singularity University, a graduate-level Silicon Valley institution that counsels the world's leaders on exponentially growing technologies.
As an entrepreneur, Diamandis has started over 20 companies in the areas of longevity, space, venture capital and education. He is co-founder of BOLD Capital Partners, a venture fund with $250M investing in exponential technologies, and co-founder and Vice Chairman of Celularity, Inc., a cellular therapeutics company.
Visit website: https://www.diamandis.com/
See also: XPRIZE - Non-profit organization that designs and hosts public competitions intended to encourage technological development
Details last updated 24-Jun-2019
29-Nov-2023 to 30-Nov-2023
Longevity summit organised by Hevolution Foundation (Riyadh,Saudi Arabia)
Peter Diamandis delivered a keynote on inspiring and enabling progress in the field of longevity
13-Jun-2024 to 16-Jun-2024
Event gathering Global Longevity and Rejuvenation community in Dublin by LEV Foundation (Dublin, Ireland)
Live stream of XPRIZE Healthspan launch on YouTube
Manifesto for the future that is grounded in practical solutions written by Peter H. Diamandis
Peter Diamandis shares insights on living longer through tech innovation
10 years of functional age-reversal in 65-80 year olds within the next 7 years... bring it on!!!
Celularity is a spinout from Celgene, a global biopharmaceutical company. Hopes to use stem cell...
<p>Interesting interview with Peter Diamandis - founder of the X Prize Foundation and Singularity...
HLI (Human Longevity Inc) has purchased two Illumina HiSeq X Ten Sequencing Systems to study inte...
Insilico Medicine is slashing the cost of drug development